Uddhammar A, Roos G, Näsman B, Dahlqvist S R
Department of Rheumatology, Umeå University Hospital, Sweden.
Clin Rheumatol. 1995 Jan;14(1):62-7. doi: 10.1007/BF02208086.
Peripheral blood lymphocytes from 23 patients with polymyalgia rheumatica (PMR) were characterized using monoclonal antibodies and flow cytometry in a two-year prospective study. There were no significant differences in absolute numbers or relative percentages of lymphocytes or CD3+, CD4+, CD8+ T cells or the CD4+ T cell functional subsets, virgin (CD4+CD45RA+) and memory (CD4+CD29+) T cells, in patients before or during corticosteroid treatment compared to controls. Previous reports on decreased levels of CD8+ T cells as a characteristic of PMR/giant cell arteritis was not confirmed. The absolute number and relative percentage of lymphocytes with natural killer cell activity, CD16+ CD56+ cells, were significantly lower in patients with active untreated PMR as well as during corticosteroid treatment compared to controls, but at the two-year follow-up the difference was less marked.
在一项为期两年的前瞻性研究中,使用单克隆抗体和流式细胞术对23例风湿性多肌痛(PMR)患者的外周血淋巴细胞进行了特征分析。与对照组相比,在接受皮质类固醇治疗前或治疗期间,患者淋巴细胞或CD3 +、CD4 +、CD8 + T细胞以及CD4 + T细胞功能亚群(初始型(CD4 + CD45RA +)和记忆型(CD4 + CD29 +)T细胞)的绝对数量或相对百分比均无显著差异。先前关于CD8 + T细胞水平降低是PMR/巨细胞动脉炎特征的报道未得到证实。与对照组相比,未经治疗的活动性PMR患者以及在皮质类固醇治疗期间,具有自然杀伤细胞活性的淋巴细胞(CD16 + CD56 +细胞)的绝对数量和相对百分比显著降低,但在两年随访时差异不那么明显。